Resultats de la cerca - Pieters, Rob
- Mostrar 1 - 20 resultats de 133
- Anar a la pàgina següent
-
1
-
2
-
3
-
4
-
5
-
6
Cytotoxic Effects of Vitamin A in Combination with Vincristine, Daunorubicin and 6‐Thioguanine upon Cells from Lymphoblastic Leukemic Patients per Pieters, Rob, Huismans, Dieuwke R., Loonen, Anne H., Hählen, Karel, Veerman, Anjo J. P.
Publicat 1991Text -
7
Methotrexate-induced side effects are not due to differences in pharmacokinetics in children with Down syndrome and acute lymphoblastic leukemia per Buitenkamp, Trudy D., Mathôt, Ron A.A., de Haas, Valerie, Pieters, Rob, Zwaan, C. Michel
Publicat 2010Text -
8
-
9
Trametinib inhibits RAS-mutant MLL-rearranged acute lymphoblastic leukemia at specific niche sites and reduces ERK phosphorylation in vivo per Kerstjens, Mark, Pinhancos, Sandra S., Castro, Patricia Garrido, Schneider, Pauline, Wander, Priscilla, Pieters, Rob, Stam, Ronald W.
Publicat 2018Text -
10
Irinotecan Induces Disease Remission in Xenograft Mouse Models of Pediatric MLL-Rearranged Acute Lymphoblastic Leukemia per Kerstjens, Mark, Garrido Castro, Patricia, Pinhanços, Sandra S., Schneider, Pauline, Wander, Priscilla, Pieters, Rob, Stam, Ronald W.
Publicat 2021Text -
11
Characterization of a pediatric T-cell acute lymphoblastic leukemia patient with simultaneous LYL1 and LMO2 rearrangements per Homminga, Irene, Vuerhard, Maartje J., Langerak, Anton W., Buijs-Gladdines, Jessica, Pieters, Rob, Meijerink, Jules P.P.
Publicat 2012Text -
12
MEK inhibition is a promising therapeutic strategy for MLL-rearranged infant acute lymphoblastic leukemia patients carrying RAS mutations per Kerstjens, Mark, Driessen, Emma M.C., Willekes, Merel, Pinhanços, Sandra S., Schneider, Pauline, Pieters, Rob, Stam, Ronald W.
Publicat 2016Text -
13
-
14
Effect of Treatment in a Specialized Pediatric Hemato-Oncology Setting on 5-Year Survival in Acute Lymphoblastic Leukemia: A Quasi-Experimental Study per van der Linde, Margrietha, van Leeuwen, Nikki, Eijkenaar, Frank, Rijneveld, Anita W., Pieters, Rob, Karim-Kos, Henrike E.
Publicat 2022Text -
15
MLL fusion-driven activation of CDK6 potentiates proliferation in MLL-rearranged infant ALL per van der Linden, Marieke H, Willekes, Merel, van Roon, Eddy, Seslija, Lidija, Schneider, Pauline, Pieters, Rob, Stam, Ronald W
Publicat 2014Text -
16
-
17
High PDGFRA expression does not serve as an effective therapeutic target in ERG-deleted B-cell precursor acute lymphoblastic leukemia per Jerchel, Isabel S., Chatzivasileiou, Danai, Hoogkamer, Alex Q., Boer, Judith M., Beverloo, H. Berna, Pieters, Rob, den Boer, Monique L.
Publicat 2018Text -
18
Recent perspectives on the association between osteonecrosis and bone mineral density decline in childhood acute lymphoblastic leukemia per van Atteveld, Jenneke E, de Winter, Demi TC, Pieters, Rob, Neggers, Sebastian JCMM, van den Heuvel-Eibrink, Marry M
Publicat 2021Text -
19
L-asparaginase treatment in acute lymphoblastic leukemia: a focus on Erwinia asparaginase per Pieters, Rob, Hunger, Stephen P, Boos, Joachim, Rizzari, Carmelo, Silverman, Lewis, Baruchel, Andre, Goekbuget, Nicola, Schrappe, Martin, Pui, Ching-Hon
Publicat 2010Text -
20
Alterations in Epithelial and Mesenchymal Intestinal Gene Expression During Doxorubicin-Induced Mucositis in Mice per de Koning, Barbara A E, Lindenbergh-Kortleve, Dicky J., Pieters, Rob, Büller, Hans A., Renes, Ingrid B., Einerhand, Alexandra W. C.
Publicat 2007Text